샘플 요청 목록

 카트 문의
시장보고서
상품코드
1782831

세계의 로라타딘(Loratadine) 시장

Loratadine
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 373 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

로라타딘 세계 시장은 2030년까지 3억 4,750만 달러에 달할 전망

2024년에 3억 630만 달러로 추정되는 로라타딘 세계 시장은 2024년부터 2030년까지 CAGR 2.1%로 성장하여 2030년에는 3억 4,750만 달러에 달할 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 정제는 CAGR 2.0%를 기록하며 분석 기간 종료시에는 1억 5,600만 달러에 달할 것으로 예측됩니다. CAGR은 2.7%를 기록할 것으로 예상됩니다.

미국 시장은 8,340만 달러로 추정, 중국은 CAGR 4.0%로 성장할 것으로 예측

미국의 로라타딘 시장은 2024년에 8,340만 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 2030년까지 6,500만 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2024-2030년 CAGR은 4.0%를 기록할 것으로 예상됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석 기간 동안 CAGR은 각각 0.9%와 1.8%로 예측됩니다. 유럽에서는 독일이 CAGR 1.2%로 성장할 것으로 예측됩니다.

세계의 로라타딘 시장 - 주요 동향과 촉진요인 정리

로라타딘이란 무엇이며, 왜 알레르기 관리에 널리 사용되는가?

로라타딘은 알레르기성 비염(꽃가루 알레르기), 두드러기(두드러기), 기타 피부 알레르기 및 호흡기 알레르기 증상을 치료하는 데 일반적으로 사용되는 2세대 항히스타민제입니다. 재채기, 콧물, 눈 가려움증, 피부 발진 등 알레르기 증상을 유발하는 체내 물질인 히스타민의 작용을 억제해 효과를 발휘합니다. 1세대 항히스타민제와는 달리 로라타딘은 진정 작용이 없기 때문에 특히 일하는 성인과 어린이가 낮에 사용하기에 매우 적합합니다. 정제, 시럽제, 구강붕해정 등 다양한 제형이 있으며, 전 세계적으로 수많은 브랜드명으로 판매되고 있는데, 그 중 클라리틴이 가장 인지도가 높습니다.

많은 국가에서 일반의약품(OTC)으로 판매되고 있어 처방전 없이도 경증에서 중등도의 알레르기 증상을 자가 관리할 수 있어 그 인기가 더욱 높아지고 있습니다. 로라타딘은 증상 완화를 위해 충혈제거제나 코르티코스테로이드제와의 병용요법에도 많이 사용됩니다. 계절성 알레르기의 증가, 환경 오염, 실내 알레르겐에 대한 과민 반응으로 인해 로라타딘은 전 세계적으로 안정적인 수요를 유지하고 있으며, 소매 약국과 의료 서비스 제공자 채널 모두에서 항히스타민제 계열의 스테디셀러로 자리 잡았습니다.

어떤 시장 동향과 혁신이 로라타딘의 상황을 형성하고 있는가?

로라타딘 시장은 사용하기 쉬운 제형, 병용요법, 제네릭 대체제에 대한 수요 증가와 함께 진화하고 있습니다. 특히 소아 및 노약자를 대상으로 편의성과 작용 발현성을 향상시키기 위해 속방정이나 액상 겔 형태로의 전환이 진행되고 있습니다. 또한, 로라타딘과 소이드에페드린(충혈제거제)을 결합한 듀얼 액션 제품을 개발하여 한 번의 복용으로 알레르기 및 부비동 증상을 모두 치료함으로써 여러 가지 상기도 질환을 앓고 있는 소비자의 니즈를 충족시키고 있습니다.

또한, 오리지널 의약품의 특허가 만료됨에 따라 비용 효율적인 제네릭 의약품의 생산과 공급이 급증하고 있으며, 신흥 시장에서의 구매 편의성과 접근성이 향상되고 있습니다. 펙소페나딘이나 레보세티리딘과 같은 새로운 항히스타민제가 출시되었음에도 불구하고, 졸지 않고 오래 지속되는 알레르기 증상 완화를 원하는 소비자의 선호는 로라타딘의 경쟁력을 유지하고 있습니다. E-Commerce 채널과 원격의료 플랫폼은 시장의 저변을 더욱 넓히고, 간편한 구매와 디지털 처방전 전달을 가능하게 하고 있습니다. 또한, 약물전달시스템의 연구개발로 서방형 제제나 비강용 제제가 시장에 출시되어 치료적 유용성이 다양해지고 환자의 복약순응도가 향상될 것으로 기대되고 있습니다.

세계 로라타딘 시장의 성장을 촉진하는 요인은 무엇인가?

세계 로라타딘 시장의 성장은 알레르기 질환 발생률 증가, OTC 의약품 부문 확대, 비진정형 항히스타민제에 대한 인식 증가 등 여러 요인에 의해 주도되고 있습니다. 도시화, 대기오염, 기후변화가 심화됨에 따라 계절성 및 연중 알레르기 유병률은 증가 추세에 있으며, 더 많은 소비자들이 신뢰할 수 있고 즉각적인 증상 완화를 원하고 있습니다. 로라타딘의 안전성 프로파일과 오랜 기간 동안 입증된 효과로 인해 자가 투약과 의사 처방 모두에서 이 의약품은 신뢰할 수 있는 선택이 되었습니다.

또 다른 중요한 성장 요인은 특히 아시아태평양, 라틴아메리카, 아프리카의 일부 비용에 민감한 헬스케어 시장에서 제네릭 의약품에 대한 수요가 증가하고 있다는 점입니다. 따라서 제약사들은 지역적 파트너십과 규제 당국의 승인을 통해 로라타딘의 생산과 유통을 확대하기 위해 노력하고 있습니다. 신흥국의 의료비 지출 증가, 알레르기 증상에 대한 인식 증가, 보험 적용 범위 확대 등도 판매량을 증가시키는 요인으로 작용하고 있습니다. 또한, 로라타딘이 국가 필수의약품 목록과 공중보건 프로그램에 등재됨에 따라 기본적인 알레르기 치료 프로토콜에서 로라타딘의 중요성이 강화되어 세계 시장의 지속적이고 광범위한 성장에 기여하고 있습니다.

부문

제형(정제, 캡슐제, 시럽제, 기타 제형), 등급(USP 표준 등급, EP 표준 등급, 의약품 표준 등급, 기타 등급), 최종사용(소매 약국, 병원 약국, 온라인 약국)

조사 대상 기업 사례

  • Apotex Inc.
  • Bayer AG
  • Cadila Pharmaceuticals
  • Dr. Reddy's Laboratories
  • Glenmark Pharmaceuticals
  • Hetero Drugs Limited
  • Lupin Limited
  • Merck & Co., Inc.
  • Morepen Laboratories Ltd.
  • Mylan N.V.
  • Perrigo Company plc
  • Pfizer Inc.
  • Ranbaxy Laboratories Ltd.
  • Schering-Plough(now part of Merck)
  • Sun Pharmaceutical Industries Ltd.
  • Taro Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Wockhardt Ltd.
  • Zydus Cadila

AI 통합

우리는 검증된 전문가 컨텐츠와 AI 툴을 통해 시장 정보와 경쟁 정보를 혁신하고 있습니다.

Global Industry Analysts는 LLM 및 업계 고유의 SLM을 조회하는 일반적인 규범을 따르는 대신 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측하고 있습니다. 이러한 복잡하고 다면적인 시장 역학은 매출원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예상됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

ksm 25.08.08

Global Loratadine Market to Reach US$347.5 Million by 2030

The global market for Loratadine estimated at US$306.3 Million in the year 2024, is expected to reach US$347.5 Million by 2030, growing at a CAGR of 2.1% over the analysis period 2024-2030. Tablets, one of the segments analyzed in the report, is expected to record a 2.0% CAGR and reach US$156.0 Million by the end of the analysis period. Growth in the Capsules segment is estimated at 2.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$83.4 Million While China is Forecast to Grow at 4.0% CAGR

The Loratadine market in the U.S. is estimated at US$83.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$65.0 Million by the year 2030 trailing a CAGR of 4.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 0.9% and 1.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.2% CAGR.

Global Loratadine Market - Key Trends & Drivers Summarized

What Is Loratadine and Why Is It Widely Used in Allergy Management?

Loratadine is a second-generation antihistamine commonly used to treat symptoms of allergic rhinitis (hay fever), urticaria (hives), and other skin or respiratory allergies. It works by blocking the action of histamine, a substance in the body that causes allergic symptoms such as sneezing, runny nose, itchy eyes, and skin rashes. Unlike first-generation antihistamines, loratadine is non-sedating, making it highly favorable for daytime use, especially among working adults and children. It is available in various forms including tablets, syrups, and orally disintegrating tablets, and is marketed under numerous brand names globally, with Claritin being among the most recognized.

Its over-the-counter (OTC) availability in many countries has further boosted its popularity, allowing consumers to self-manage mild to moderate allergy symptoms without needing a prescription. Loratadine is also included in numerous combination therapies with decongestants or corticosteroids for enhanced symptom relief. The increasing prevalence of seasonal allergies, environmental pollution, and sensitivity to indoor allergens has maintained consistent global demand for loratadine, making it a staple in the antihistamine drug class within both retail pharmacy and healthcare provider channels.

What Market Trends and Innovations Are Shaping the Loratadine Landscape?

The loratadine market is evolving with the rising demand for user-friendly formulations, combination therapies, and generic alternatives. There has been a growing shift toward fast-dissolving tablets and liquid gels to improve convenience and onset of action, particularly for pediatric and geriatric populations. Pharmaceutical companies are also developing dual-action products that combine loratadine with pseudoephedrine (a decongestant) to treat both allergy and sinus symptoms in a single dose-catering to the needs of consumers with multiple upper respiratory complaints.

Additionally, the expiration of original patents has led to a surge in the production and availability of cost-effective generic versions, increasing affordability and accessibility in emerging markets. Consumer preferences for non-drowsy, long-lasting allergy relief have kept loratadine competitive despite the availability of newer antihistamines like fexofenadine or levocetirizine. E-commerce channels and telehealth platforms have further expanded the market’s reach, enabling easy purchase and digital prescription fulfillment. Moreover, ongoing R&D in drug delivery systems is expected to bring extended-release and intranasal loratadine formulations to market, diversifying its therapeutic utility and improving patient adherence.

What Factors Are Driving Growth in the Global Loratadine Market?

The growth in the global loratadine market is driven by several factors, including increasing incidence of allergic conditions, the expanding OTC pharmaceutical segment, and the growing awareness of non-sedating antihistamines. As urbanization, air pollution, and climate variability intensify, the prevalence of seasonal and perennial allergies is on the rise, leading more consumers to seek reliable, fast-acting symptom relief. Loratadine’s safety profile and long-established efficacy make it a go-to option for both self-medication and physician-prescribed regimens.

Another key growth driver is the rising demand for generic drugs, particularly in cost-sensitive healthcare markets across Asia-Pacific, Latin America, and parts of Africa. This is encouraging pharmaceutical companies to expand loratadine production and distribution through regional partnerships and regulatory approvals. Increased healthcare spending, higher awareness of allergy symptoms, and broader insurance coverage in developing economies are also boosting sales volume. Additionally, the inclusion of loratadine in national essential medicines lists and public health programs reinforces its importance in basic allergy treatment protocols, contributing to sustained and widespread global market growth.

SCOPE OF STUDY:

The report analyzes the Loratadine market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Form (Tablets, Capsules, Syrups, Other Forms); Grade (USP Standard Grade, EP Standard Grade, Medicine Standard Grade, Other Grades); End-Use (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

  • Apotex Inc.
  • Bayer AG
  • Cadila Pharmaceuticals
  • Dr. Reddy's Laboratories
  • Glenmark Pharmaceuticals
  • Hetero Drugs Limited
  • Lupin Limited
  • Merck & Co., Inc.
  • Morepen Laboratories Ltd.
  • Mylan N.V.
  • Perrigo Company plc
  • Pfizer Inc.
  • Ranbaxy Laboratories Ltd.
  • Schering-Plough (now part of Merck)
  • Sun Pharmaceutical Industries Ltd.
  • Taro Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Wockhardt Ltd.
  • Zydus Cadila

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Loratadine - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Allergic Rhinitis and Seasonal Allergies Drives Demand for Loratadine-Based Therapies
    • Increased Availability of Loratadine as an OTC Drug Expands Consumer Access and Market Penetration
    • Growing Preference for Non-Sedating Antihistamines Strengthens Loratadines Competitive Position
    • Expansion of Self-Care and Self-Medication Trends Spurs Demand for Oral Allergy Treatments
    • Favorable Safety Profile and Minimal Side Effects Sustain Long-Term Use Across Age Groups
    • Growing Geriatric Population With Respiratory Sensitivities Expands Addressable Market
    • Increased Online Pharmacy and E-Commerce Sales Channels Broaden Distribution Reach
    • Combination Formulations with Decongestants and Nasal Sprays Enhance Market Differentiation
    • Strong Generic Drug Penetration Encourages Competitive Pricing and Volume-Driven Growth
    • Expanding Access in Emerging Economies Supports Wider Adoption of Affordable Allergy Medications
    • Pediatric Allergy Market Growth Boosts Use of Syrup and Chewable Loratadine Formulations
    • Changing Climatic Conditions and Rising Pollution Levels Drive Up Incidences of Allergic Reactions
    • Hospital and Clinic Recommendations for OTC Antihistamines Promote Brand Trust and Uptake
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Loratadine Market Analysis of Annual Sales in US$ for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Loratadine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Loratadine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Loratadine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Tablets by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Tablets by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Tablets by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Capsules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Capsules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Capsules by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Syrups by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Syrups by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Syrups by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Forms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Forms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Other Forms by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Hospital Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Online Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Online Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Online Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Retail Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for USP Standard Grade by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for USP Standard Grade by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for USP Standard Grade by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for EP Standard Grade by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for EP Standard Grade by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for EP Standard Grade by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Medicine Standard Grade by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Medicine Standard Grade by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Medicine Standard Grade by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Other Grades by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Other Grades by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Other Grades by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Loratadine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for Loratadine by Form - Tablets, Capsules, Syrups and Other Forms - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Loratadine by Form - Tablets, Capsules, Syrups and Other Forms Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Loratadine by Form - Percentage Breakdown of Value Sales for Tablets, Capsules, Syrups and Other Forms for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Loratadine by End-Use - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Loratadine by End-Use - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Loratadine by End-Use - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Loratadine by Grade - USP Standard Grade, EP Standard Grade, Medicine Standard Grade and Other Grades - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Loratadine by Grade - USP Standard Grade, EP Standard Grade, Medicine Standard Grade and Other Grades Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for Loratadine by Grade - Percentage Breakdown of Value Sales for USP Standard Grade, EP Standard Grade, Medicine Standard Grade and Other Grades for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Loratadine by Form - Tablets, Capsules, Syrups and Other Forms - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Loratadine by Form - Tablets, Capsules, Syrups and Other Forms Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Loratadine by Form - Percentage Breakdown of Value Sales for Tablets, Capsules, Syrups and Other Forms for the Years 2015, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Loratadine by End-Use - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Loratadine by End-Use - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Loratadine by End-Use - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Loratadine by Grade - USP Standard Grade, EP Standard Grade, Medicine Standard Grade and Other Grades - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Loratadine by Grade - USP Standard Grade, EP Standard Grade, Medicine Standard Grade and Other Grades Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for Loratadine by Grade - Percentage Breakdown of Value Sales for USP Standard Grade, EP Standard Grade, Medicine Standard Grade and Other Grades for the Years 2015, 2025 & 2030
  • JAPAN
    • Loratadine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Loratadine by Form - Tablets, Capsules, Syrups and Other Forms - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Loratadine by Form - Tablets, Capsules, Syrups and Other Forms Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Loratadine by Form - Percentage Breakdown of Value Sales for Tablets, Capsules, Syrups and Other Forms for the Years 2015, 2025 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Loratadine by End-Use - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Loratadine by End-Use - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Loratadine by End-Use - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Loratadine by Grade - USP Standard Grade, EP Standard Grade, Medicine Standard Grade and Other Grades - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Loratadine by Grade - USP Standard Grade, EP Standard Grade, Medicine Standard Grade and Other Grades Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 64: Japan 15-Year Perspective for Loratadine by Grade - Percentage Breakdown of Value Sales for USP Standard Grade, EP Standard Grade, Medicine Standard Grade and Other Grades for the Years 2015, 2025 & 2030
  • CHINA
    • Loratadine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 65: China Recent Past, Current & Future Analysis for Loratadine by Form - Tablets, Capsules, Syrups and Other Forms - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Loratadine by Form - Tablets, Capsules, Syrups and Other Forms Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Loratadine by Form - Percentage Breakdown of Value Sales for Tablets, Capsules, Syrups and Other Forms for the Years 2015, 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Loratadine by End-Use - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Loratadine by End-Use - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for Loratadine by End-Use - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Loratadine by Grade - USP Standard Grade, EP Standard Grade, Medicine Standard Grade and Other Grades - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Loratadine by Grade - USP Standard Grade, EP Standard Grade, Medicine Standard Grade and Other Grades Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 73: China 15-Year Perspective for Loratadine by Grade - Percentage Breakdown of Value Sales for USP Standard Grade, EP Standard Grade, Medicine Standard Grade and Other Grades for the Years 2015, 2025 & 2030
  • EUROPE
    • Loratadine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Loratadine by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Loratadine by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Loratadine by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Loratadine by Form - Tablets, Capsules, Syrups and Other Forms - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Loratadine by Form - Tablets, Capsules, Syrups and Other Forms Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Loratadine by Form - Percentage Breakdown of Value Sales for Tablets, Capsules, Syrups and Other Forms for the Years 2015, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Loratadine by End-Use - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Loratadine by End-Use - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Loratadine by End-Use - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Loratadine by Grade - USP Standard Grade, EP Standard Grade, Medicine Standard Grade and Other Grades - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Loratadine by Grade - USP Standard Grade, EP Standard Grade, Medicine Standard Grade and Other Grades Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 85: Europe 15-Year Perspective for Loratadine by Grade - Percentage Breakdown of Value Sales for USP Standard Grade, EP Standard Grade, Medicine Standard Grade and Other Grades for the Years 2015, 2025 & 2030
  • FRANCE
    • Loratadine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 86: France Recent Past, Current & Future Analysis for Loratadine by Form - Tablets, Capsules, Syrups and Other Forms - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Loratadine by Form - Tablets, Capsules, Syrups and Other Forms Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Loratadine by Form - Percentage Breakdown of Value Sales for Tablets, Capsules, Syrups and Other Forms for the Years 2015, 2025 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Loratadine by End-Use - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Loratadine by End-Use - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 91: France 15-Year Perspective for Loratadine by End-Use - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Loratadine by Grade - USP Standard Grade, EP Standard Grade, Medicine Standard Grade and Other Grades - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Loratadine by Grade - USP Standard Grade, EP Standard Grade, Medicine Standard Grade and Other Grades Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 94: France 15-Year Perspective for Loratadine by Grade - Percentage Breakdown of Value Sales for USP Standard Grade, EP Standard Grade, Medicine Standard Grade and Other Grades for the Years 2015, 2025 & 2030
  • GERMANY
    • Loratadine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Loratadine by Form - Tablets, Capsules, Syrups and Other Forms - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Loratadine by Form - Tablets, Capsules, Syrups and Other Forms Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Loratadine by Form - Percentage Breakdown of Value Sales for Tablets, Capsules, Syrups and Other Forms for the Years 2015, 2025 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Loratadine by End-Use - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Loratadine by End-Use - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 100: Germany 15-Year Perspective for Loratadine by End-Use - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Loratadine by Grade - USP Standard Grade, EP Standard Grade, Medicine Standard Grade and Other Grades - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Loratadine by Grade - USP Standard Grade, EP Standard Grade, Medicine Standard Grade and Other Grades Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 103: Germany 15-Year Perspective for Loratadine by Grade - Percentage Breakdown of Value Sales for USP Standard Grade, EP Standard Grade, Medicine Standard Grade and Other Grades for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Loratadine by Form - Tablets, Capsules, Syrups and Other Forms - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Loratadine by Form - Tablets, Capsules, Syrups and Other Forms Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Loratadine by Form - Percentage Breakdown of Value Sales for Tablets, Capsules, Syrups and Other Forms for the Years 2015, 2025 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Loratadine by End-Use - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Loratadine by End-Use - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 109: Italy 15-Year Perspective for Loratadine by End-Use - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Loratadine by Grade - USP Standard Grade, EP Standard Grade, Medicine Standard Grade and Other Grades - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Loratadine by Grade - USP Standard Grade, EP Standard Grade, Medicine Standard Grade and Other Grades Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 112: Italy 15-Year Perspective for Loratadine by Grade - Percentage Breakdown of Value Sales for USP Standard Grade, EP Standard Grade, Medicine Standard Grade and Other Grades for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Loratadine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 113: UK Recent Past, Current & Future Analysis for Loratadine by Form - Tablets, Capsules, Syrups and Other Forms - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Loratadine by Form - Tablets, Capsules, Syrups and Other Forms Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Loratadine by Form - Percentage Breakdown of Value Sales for Tablets, Capsules, Syrups and Other Forms for the Years 2015, 2025 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Loratadine by End-Use - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Loratadine by End-Use - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 118: UK 15-Year Perspective for Loratadine by End-Use - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for Loratadine by Grade - USP Standard Grade, EP Standard Grade, Medicine Standard Grade and Other Grades - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Loratadine by Grade - USP Standard Grade, EP Standard Grade, Medicine Standard Grade and Other Grades Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 121: UK 15-Year Perspective for Loratadine by Grade - Percentage Breakdown of Value Sales for USP Standard Grade, EP Standard Grade, Medicine Standard Grade and Other Grades for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Loratadine by Form - Tablets, Capsules, Syrups and Other Forms - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Loratadine by Form - Tablets, Capsules, Syrups and Other Forms Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 124: Spain 15-Year Perspective for Loratadine by Form - Percentage Breakdown of Value Sales for Tablets, Capsules, Syrups and Other Forms for the Years 2015, 2025 & 2030
    • TABLE 125: Spain Recent Past, Current & Future Analysis for Loratadine by End-Use - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Spain Historic Review for Loratadine by End-Use - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 127: Spain 15-Year Perspective for Loratadine by End-Use - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 128: Spain Recent Past, Current & Future Analysis for Loratadine by Grade - USP Standard Grade, EP Standard Grade, Medicine Standard Grade and Other Grades - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Spain Historic Review for Loratadine by Grade - USP Standard Grade, EP Standard Grade, Medicine Standard Grade and Other Grades Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 130: Spain 15-Year Perspective for Loratadine by Grade - Percentage Breakdown of Value Sales for USP Standard Grade, EP Standard Grade, Medicine Standard Grade and Other Grades for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Loratadine by Form - Tablets, Capsules, Syrups and Other Forms - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Loratadine by Form - Tablets, Capsules, Syrups and Other Forms Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 133: Russia 15-Year Perspective for Loratadine by Form - Percentage Breakdown of Value Sales for Tablets, Capsules, Syrups and Other Forms for the Years 2015, 2025 & 2030
    • TABLE 134: Russia Recent Past, Current & Future Analysis for Loratadine by End-Use - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Russia Historic Review for Loratadine by End-Use - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 136: Russia 15-Year Perspective for Loratadine by End-Use - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 137: Russia Recent Past, Current & Future Analysis for Loratadine by Grade - USP Standard Grade, EP Standard Grade, Medicine Standard Grade and Other Grades - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Russia Historic Review for Loratadine by Grade - USP Standard Grade, EP Standard Grade, Medicine Standard Grade and Other Grades Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 139: Russia 15-Year Perspective for Loratadine by Grade - Percentage Breakdown of Value Sales for USP Standard Grade, EP Standard Grade, Medicine Standard Grade and Other Grades for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Loratadine by Form - Tablets, Capsules, Syrups and Other Forms - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Loratadine by Form - Tablets, Capsules, Syrups and Other Forms Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of Europe 15-Year Perspective for Loratadine by Form - Percentage Breakdown of Value Sales for Tablets, Capsules, Syrups and Other Forms for the Years 2015, 2025 & 2030
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Loratadine by End-Use - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for Loratadine by End-Use - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of Europe 15-Year Perspective for Loratadine by End-Use - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Loratadine by Grade - USP Standard Grade, EP Standard Grade, Medicine Standard Grade and Other Grades - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of Europe Historic Review for Loratadine by Grade - USP Standard Grade, EP Standard Grade, Medicine Standard Grade and Other Grades Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 148: Rest of Europe 15-Year Perspective for Loratadine by Grade - Percentage Breakdown of Value Sales for USP Standard Grade, EP Standard Grade, Medicine Standard Grade and Other Grades for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Loratadine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Loratadine by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Loratadine by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for Loratadine by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Loratadine by Form - Tablets, Capsules, Syrups and Other Forms - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Loratadine by Form - Tablets, Capsules, Syrups and Other Forms Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 15-Year Perspective for Loratadine by Form - Percentage Breakdown of Value Sales for Tablets, Capsules, Syrups and Other Forms for the Years 2015, 2025 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Loratadine by End-Use - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Loratadine by End-Use - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 157: Asia-Pacific 15-Year Perspective for Loratadine by End-Use - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Loratadine by Grade - USP Standard Grade, EP Standard Grade, Medicine Standard Grade and Other Grades - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Asia-Pacific Historic Review for Loratadine by Grade - USP Standard Grade, EP Standard Grade, Medicine Standard Grade and Other Grades Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 160: Asia-Pacific 15-Year Perspective for Loratadine by Grade - Percentage Breakdown of Value Sales for USP Standard Grade, EP Standard Grade, Medicine Standard Grade and Other Grades for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Loratadine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Loratadine by Form - Tablets, Capsules, Syrups and Other Forms - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Loratadine by Form - Tablets, Capsules, Syrups and Other Forms Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 163: Australia 15-Year Perspective for Loratadine by Form - Percentage Breakdown of Value Sales for Tablets, Capsules, Syrups and Other Forms for the Years 2015, 2025 & 2030
    • TABLE 164: Australia Recent Past, Current & Future Analysis for Loratadine by End-Use - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Australia Historic Review for Loratadine by End-Use - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 166: Australia 15-Year Perspective for Loratadine by End-Use - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 167: Australia Recent Past, Current & Future Analysis for Loratadine by Grade - USP Standard Grade, EP Standard Grade, Medicine Standard Grade and Other Grades - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Australia Historic Review for Loratadine by Grade - USP Standard Grade, EP Standard Grade, Medicine Standard Grade and Other Grades Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 169: Australia 15-Year Perspective for Loratadine by Grade - Percentage Breakdown of Value Sales for USP Standard Grade, EP Standard Grade, Medicine Standard Grade and Other Grades for the Years 2015, 2025 & 2030
  • INDIA
    • Loratadine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 170: India Recent Past, Current & Future Analysis for Loratadine by Form - Tablets, Capsules, Syrups and Other Forms - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Loratadine by Form - Tablets, Capsules, Syrups and Other Forms Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 172: India 15-Year Perspective for Loratadine by Form - Percentage Breakdown of Value Sales for Tablets, Capsules, Syrups and Other Forms for the Years 2015, 2025 & 2030
    • TABLE 173: India Recent Past, Current & Future Analysis for Loratadine by End-Use - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 174: India Historic Review for Loratadine by End-Use - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 175: India 15-Year Perspective for Loratadine by End-Use - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 176: India Recent Past, Current & Future Analysis for Loratadine by Grade - USP Standard Grade, EP Standard Grade, Medicine Standard Grade and Other Grades - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 177: India Historic Review for Loratadine by Grade - USP Standard Grade, EP Standard Grade, Medicine Standard Grade and Other Grades Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 178: India 15-Year Perspective for Loratadine by Grade - Percentage Breakdown of Value Sales for USP Standard Grade, EP Standard Grade, Medicine Standard Grade and Other Grades for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Loratadine by Form - Tablets, Capsules, Syrups and Other Forms - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Loratadine by Form - Tablets, Capsules, Syrups and Other Forms Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 181: South Korea 15-Year Perspective for Loratadine by Form - Percentage Breakdown of Value Sales for Tablets, Capsules, Syrups and Other Forms for the Years 2015, 2025 & 2030
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for Loratadine by End-Use - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 183: South Korea Historic Review for Loratadine by End-Use - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 184: South Korea 15-Year Perspective for Loratadine by End-Use - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 185: South Korea Recent Past, Current & Future Analysis for Loratadine by Grade - USP Standard Grade, EP Standard Grade, Medicine Standard Grade and Other Grades - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 186: South Korea Historic Review for Loratadine by Grade - USP Standard Grade, EP Standard Grade, Medicine Standard Grade and Other Grades Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 187: South Korea 15-Year Perspective for Loratadine by Grade - Percentage Breakdown of Value Sales for USP Standard Grade, EP Standard Grade, Medicine Standard Grade and Other Grades for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Loratadine by Form - Tablets, Capsules, Syrups and Other Forms - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Loratadine by Form - Tablets, Capsules, Syrups and Other Forms Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Loratadine by Form - Percentage Breakdown of Value Sales for Tablets, Capsules, Syrups and Other Forms for the Years 2015, 2025 & 2030
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Loratadine by End-Use - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for Loratadine by End-Use - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Loratadine by End-Use - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Loratadine by Grade - USP Standard Grade, EP Standard Grade, Medicine Standard Grade and Other Grades - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Asia-Pacific Historic Review for Loratadine by Grade - USP Standard Grade, EP Standard Grade, Medicine Standard Grade and Other Grades Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 196: Rest of Asia-Pacific 15-Year Perspective for Loratadine by Grade - Percentage Breakdown of Value Sales for USP Standard Grade, EP Standard Grade, Medicine Standard Grade and Other Grades for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Loratadine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Loratadine by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Loratadine by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 199: Latin America 15-Year Perspective for Loratadine by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Loratadine by Form - Tablets, Capsules, Syrups and Other Forms - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Loratadine by Form - Tablets, Capsules, Syrups and Other Forms Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 202: Latin America 15-Year Perspective for Loratadine by Form - Percentage Breakdown of Value Sales for Tablets, Capsules, Syrups and Other Forms for the Years 2015, 2025 & 2030
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Loratadine by End-Use - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Loratadine by End-Use - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 205: Latin America 15-Year Perspective for Loratadine by End-Use - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 206: Latin America Recent Past, Current & Future Analysis for Loratadine by Grade - USP Standard Grade, EP Standard Grade, Medicine Standard Grade and Other Grades - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Latin America Historic Review for Loratadine by Grade - USP Standard Grade, EP Standard Grade, Medicine Standard Grade and Other Grades Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 208: Latin America 15-Year Perspective for Loratadine by Grade - Percentage Breakdown of Value Sales for USP Standard Grade, EP Standard Grade, Medicine Standard Grade and Other Grades for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Loratadine by Form - Tablets, Capsules, Syrups and Other Forms - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Loratadine by Form - Tablets, Capsules, Syrups and Other Forms Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 211: Argentina 15-Year Perspective for Loratadine by Form - Percentage Breakdown of Value Sales for Tablets, Capsules, Syrups and Other Forms for the Years 2015, 2025 & 2030
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for Loratadine by End-Use - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Argentina Historic Review for Loratadine by End-Use - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 214: Argentina 15-Year Perspective for Loratadine by End-Use - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 215: Argentina Recent Past, Current & Future Analysis for Loratadine by Grade - USP Standard Grade, EP Standard Grade, Medicine Standard Grade and Other Grades - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Argentina Historic Review for Loratadine by Grade - USP Standard Grade, EP Standard Grade, Medicine Standard Grade and Other Grades Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 217: Argentina 15-Year Perspective for Loratadine by Grade - Percentage Breakdown of Value Sales for USP Standard Grade, EP Standard Grade, Medicine Standard Grade and Other Grades for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Loratadine by Form - Tablets, Capsules, Syrups and Other Forms - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Loratadine by Form - Tablets, Capsules, Syrups and Other Forms Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 220: Brazil 15-Year Perspective for Loratadine by Form - Percentage Breakdown of Value Sales for Tablets, Capsules, Syrups and Other Forms for the Years 2015, 2025 & 2030
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for Loratadine by End-Use - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Brazil Historic Review for Loratadine by End-Use - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 223: Brazil 15-Year Perspective for Loratadine by End-Use - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 224: Brazil Recent Past, Current & Future Analysis for Loratadine by Grade - USP Standard Grade, EP Standard Grade, Medicine Standard Grade and Other Grades - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Brazil Historic Review for Loratadine by Grade - USP Standard Grade, EP Standard Grade, Medicine Standard Grade and Other Grades Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 226: Brazil 15-Year Perspective for Loratadine by Grade - Percentage Breakdown of Value Sales for USP Standard Grade, EP Standard Grade, Medicine Standard Grade and Other Grades for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Loratadine by Form - Tablets, Capsules, Syrups and Other Forms - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Loratadine by Form - Tablets, Capsules, Syrups and Other Forms Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 229: Mexico 15-Year Perspective for Loratadine by Form - Percentage Breakdown of Value Sales for Tablets, Capsules, Syrups and Other Forms for the Years 2015, 2025 & 2030
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for Loratadine by End-Use - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Mexico Historic Review for Loratadine by End-Use - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 232: Mexico 15-Year Perspective for Loratadine by End-Use - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 233: Mexico Recent Past, Current & Future Analysis for Loratadine by Grade - USP Standard Grade, EP Standard Grade, Medicine Standard Grade and Other Grades - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Mexico Historic Review for Loratadine by Grade - USP Standard Grade, EP Standard Grade, Medicine Standard Grade and Other Grades Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 235: Mexico 15-Year Perspective for Loratadine by Grade - Percentage Breakdown of Value Sales for USP Standard Grade, EP Standard Grade, Medicine Standard Grade and Other Grades for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Loratadine by Form - Tablets, Capsules, Syrups and Other Forms - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Loratadine by Form - Tablets, Capsules, Syrups and Other Forms Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 238: Rest of Latin America 15-Year Perspective for Loratadine by Form - Percentage Breakdown of Value Sales for Tablets, Capsules, Syrups and Other Forms for the Years 2015, 2025 & 2030
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Loratadine by End-Use - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for Loratadine by End-Use - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 241: Rest of Latin America 15-Year Perspective for Loratadine by End-Use - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Loratadine by Grade - USP Standard Grade, EP Standard Grade, Medicine Standard Grade and Other Grades - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Rest of Latin America Historic Review for Loratadine by Grade - USP Standard Grade, EP Standard Grade, Medicine Standard Grade and Other Grades Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 244: Rest of Latin America 15-Year Perspective for Loratadine by Grade - Percentage Breakdown of Value Sales for USP Standard Grade, EP Standard Grade, Medicine Standard Grade and Other Grades for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Loratadine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Loratadine by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Loratadine by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 247: Middle East 15-Year Perspective for Loratadine by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Loratadine by Form - Tablets, Capsules, Syrups and Other Forms - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Loratadine by Form - Tablets, Capsules, Syrups and Other Forms Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 250: Middle East 15-Year Perspective for Loratadine by Form - Percentage Breakdown of Value Sales for Tablets, Capsules, Syrups and Other Forms for the Years 2015, 2025 & 2030
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Loratadine by End-Use - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Loratadine by End-Use - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 253: Middle East 15-Year Perspective for Loratadine by End-Use - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 254: Middle East Recent Past, Current & Future Analysis for Loratadine by Grade - USP Standard Grade, EP Standard Grade, Medicine Standard Grade and Other Grades - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Middle East Historic Review for Loratadine by Grade - USP Standard Grade, EP Standard Grade, Medicine Standard Grade and Other Grades Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 256: Middle East 15-Year Perspective for Loratadine by Grade - Percentage Breakdown of Value Sales for USP Standard Grade, EP Standard Grade, Medicine Standard Grade and Other Grades for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Loratadine by Form - Tablets, Capsules, Syrups and Other Forms - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for Loratadine by Form - Tablets, Capsules, Syrups and Other Forms Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 259: Iran 15-Year Perspective for Loratadine by Form - Percentage Breakdown of Value Sales for Tablets, Capsules, Syrups and Other Forms for the Years 2015, 2025 & 2030
    • TABLE 260: Iran Recent Past, Current & Future Analysis for Loratadine by End-Use - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Iran Historic Review for Loratadine by End-Use - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 262: Iran 15-Year Perspective for Loratadine by End-Use - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 263: Iran Recent Past, Current & Future Analysis for Loratadine by Grade - USP Standard Grade, EP Standard Grade, Medicine Standard Grade and Other Grades - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Iran Historic Review for Loratadine by Grade - USP Standard Grade, EP Standard Grade, Medicine Standard Grade and Other Grades Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 265: Iran 15-Year Perspective for Loratadine by Grade - Percentage Breakdown of Value Sales for USP Standard Grade, EP Standard Grade, Medicine Standard Grade and Other Grades for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Loratadine by Form - Tablets, Capsules, Syrups and Other Forms - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for Loratadine by Form - Tablets, Capsules, Syrups and Other Forms Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 268: Israel 15-Year Perspective for Loratadine by Form - Percentage Breakdown of Value Sales for Tablets, Capsules, Syrups and Other Forms for the Years 2015, 2025 & 2030
    • TABLE 269: Israel Recent Past, Current & Future Analysis for Loratadine by End-Use - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Israel Historic Review for Loratadine by End-Use - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 271: Israel 15-Year Perspective for Loratadine by End-Use - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 272: Israel Recent Past, Current & Future Analysis for Loratadine by Grade - USP Standard Grade, EP Standard Grade, Medicine Standard Grade and Other Grades - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Israel Historic Review for Loratadine by Grade - USP Standard Grade, EP Standard Grade, Medicine Standard Grade and Other Grades Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 274: Israel 15-Year Perspective for Loratadine by Grade - Percentage Breakdown of Value Sales for USP Standard Grade, EP Standard Grade, Medicine Standard Grade and Other Grades for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Loratadine by Form - Tablets, Capsules, Syrups and Other Forms - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Loratadine by Form - Tablets, Capsules, Syrups and Other Forms Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 277: Saudi Arabia 15-Year Perspective for Loratadine by Form - Percentage Breakdown of Value Sales for Tablets, Capsules, Syrups and Other Forms for the Years 2015, 2025 & 2030
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Loratadine by End-Use - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for Loratadine by End-Use - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 280: Saudi Arabia 15-Year Perspective for Loratadine by End-Use - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Loratadine by Grade - USP Standard Grade, EP Standard Grade, Medicine Standard Grade and Other Grades - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Saudi Arabia Historic Review for Loratadine by Grade - USP Standard Grade, EP Standard Grade, Medicine Standard Grade and Other Grades Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 283: Saudi Arabia 15-Year Perspective for Loratadine by Grade - Percentage Breakdown of Value Sales for USP Standard Grade, EP Standard Grade, Medicine Standard Grade and Other Grades for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Loratadine by Form - Tablets, Capsules, Syrups and Other Forms - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for Loratadine by Form - Tablets, Capsules, Syrups and Other Forms Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 286: UAE 15-Year Perspective for Loratadine by Form - Percentage Breakdown of Value Sales for Tablets, Capsules, Syrups and Other Forms for the Years 2015, 2025 & 2030
    • TABLE 287: UAE Recent Past, Current & Future Analysis for Loratadine by End-Use - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 288: UAE Historic Review for Loratadine by End-Use - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 289: UAE 15-Year Perspective for Loratadine by End-Use - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 290: UAE Recent Past, Current & Future Analysis for Loratadine by Grade - USP Standard Grade, EP Standard Grade, Medicine Standard Grade and Other Grades - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 291: UAE Historic Review for Loratadine by Grade - USP Standard Grade, EP Standard Grade, Medicine Standard Grade and Other Grades Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 292: UAE 15-Year Perspective for Loratadine by Grade - Percentage Breakdown of Value Sales for USP Standard Grade, EP Standard Grade, Medicine Standard Grade and Other Grades for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Loratadine by Form - Tablets, Capsules, Syrups and Other Forms - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Loratadine by Form - Tablets, Capsules, Syrups and Other Forms Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 295: Rest of Middle East 15-Year Perspective for Loratadine by Form - Percentage Breakdown of Value Sales for Tablets, Capsules, Syrups and Other Forms for the Years 2015, 2025 & 2030
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Loratadine by End-Use - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for Loratadine by End-Use - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 298: Rest of Middle East 15-Year Perspective for Loratadine by End-Use - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Loratadine by Grade - USP Standard Grade, EP Standard Grade, Medicine Standard Grade and Other Grades - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Rest of Middle East Historic Review for Loratadine by Grade - USP Standard Grade, EP Standard Grade, Medicine Standard Grade and Other Grades Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 301: Rest of Middle East 15-Year Perspective for Loratadine by Grade - Percentage Breakdown of Value Sales for USP Standard Grade, EP Standard Grade, Medicine Standard Grade and Other Grades for the Years 2015, 2025 & 2030
  • AFRICA
    • Loratadine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Loratadine by Form - Tablets, Capsules, Syrups and Other Forms - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for Loratadine by Form - Tablets, Capsules, Syrups and Other Forms Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 304: Africa 15-Year Perspective for Loratadine by Form - Percentage Breakdown of Value Sales for Tablets, Capsules, Syrups and Other Forms for the Years 2015, 2025 & 2030
    • TABLE 305: Africa Recent Past, Current & Future Analysis for Loratadine by End-Use - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Africa Historic Review for Loratadine by End-Use - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 307: Africa 15-Year Perspective for Loratadine by End-Use - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 308: Africa Recent Past, Current & Future Analysis for Loratadine by Grade - USP Standard Grade, EP Standard Grade, Medicine Standard Grade and Other Grades - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Africa Historic Review for Loratadine by Grade - USP Standard Grade, EP Standard Grade, Medicine Standard Grade and Other Grades Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 310: Africa 15-Year Perspective for Loratadine by Grade - Percentage Breakdown of Value Sales for USP Standard Grade, EP Standard Grade, Medicine Standard Grade and Other Grades for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제